Oubeid M, Bickel J T, Ingram E A, Scott G C
Department of Medicine, University of Missouri-Columbia Hospital and Clinics 65203.
Chest. 1990 Jul;98(1):237-9. doi: 10.1378/chest.98.1.237.
The development of pulmonary granulomatosis following intravenous injection of medications intended for oral use has been well described previously. Talc is the most commonly implicated agent. We present a case of talc granulomatosis which developed in a patient following cocaine sniffing and suggest that this may be the cause of development of granulomata in drug addicts who deny any history of intravenous drug abuse.
